Brahman Capital’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q3 | – | Sell |
-1,303,003
| Closed | -$16.1M | – | 24 |
|
2020
Q2 | $16.1M | Sell |
1,303,003
-99,119
| -7% | -$1.22M | 1.55% | 21 |
|
2020
Q1 | $12.6M | Sell |
1,402,122
-557,878
| -28% | -$5.01M | 1.48% | 13 |
|
2019
Q4 | $19.2M | Buy |
+1,960,000
| New | +$19.2M | 1.84% | 14 |
|
2019
Q2 | – | Sell |
-7,064,540
| Closed | -$111M | – | 15 |
|
2019
Q1 | $111M | Sell |
7,064,540
-5,183,566
| -42% | -$81.3M | 7.84% | 6 |
|
2018
Q4 | $189M | Buy |
12,248,106
+4,925,245
| +67% | +$75.9M | 10.92% | 5 |
|
2018
Q3 | $158M | Sell |
7,322,861
-3,274,818
| -31% | -$70.5M | 7.89% | 6 |
|
2018
Q2 | $258M | Sell |
10,597,679
-1,694,721
| -14% | -$41.2M | 12.19% | 2 |
|
2018
Q1 | $210M | Buy |
12,292,400
+2,346,888
| +24% | +$40.1M | 8.82% | 5 |
|
2017
Q4 | $188M | Buy |
+9,945,512
| New | +$188M | 7.13% | 7 |
|